首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1729411

日本表觀遺傳學市場報告（按產品、技術、應用和地區）2025-2033

Japan Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本表觀遺傳學市場規模達 1.6 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 4.57 億美元，2025-2033 年期間的成長率 (CAGR) 為 12.4%。癌症、糖尿病和心血管疾病等慢性疾病病例的不斷增加，加上對治療這些疾病的表觀遺傳學研究和診斷的需求不斷成長，是推動市場發展的主要因素。

表觀遺傳學是指在不改變底層 DNA 序列的情況下發生的基因表現變化。它涉及 DNA 及其相關蛋白質結構的修改，可以打開或關閉基因，影響生物體的特性和發育。表觀遺傳機制包括 DNA 甲基化（將甲基添加到 DNA 上）和組蛋白修飾（改變細胞核中 DNA 的包裝）。這些改變可能受到環境因素、生活方式選擇甚至跨世代經驗的影響。表觀遺傳學在胚胎髮育、細胞分化和基因活動調控等各種生物過程中扮演著至關重要的角色。它也對健康和疾病有影響，因為表觀遺傳學變化可能導致癌症、心血管疾病和精神健康障礙等疾病的發展。了解表觀遺傳學有可能闡明遺傳學和環境之間的相互作用，提供對基因調控及其對健康和福祉的影響的洞察。

日本表觀遺傳學市場趨勢：

近年來，日本的表觀遺傳學市場取得了顯著成長，這主要歸功於它有可能徹底改變人們對基因調控的理解及其在各個領域的影響。首先，次世代定序和高通量檢測等技術的進步推動了表觀遺傳學市場的發展。這些工具使研究人員能夠以前所未有的規模和精度分析 DNA 甲基化、組蛋白修飾和非編碼 RNA 表現。此外，癌症、神經系統疾病和代謝疾病等複雜疾病的盛行率不斷上升，推動了對錶觀遺傳學研究的需求。表觀遺傳改變與這些疾病的發展和進展有關，因此迫切需要有針對性的治療和診斷工具。此外，人們對錶觀遺傳學在個人化醫療中的作用的認知不斷提高，引起了製藥公司的興趣，進一步刺激了市場發展。此外，政府和私人對錶觀遺傳學研究的投資激增，促進了學術機構和生物技術公司之間的創新和合作。這項資金支持加速了表觀遺傳藥物和診斷解決方案的開發。最後，臨床環境中表觀遺傳檢測的日益普及，加上人口老化，預計將在預測期內推動日本表觀遺傳學市場的發展。

日本表觀遺傳學市場區隔：

產品洞察：

試劑
套件
- 晶片定序試劑盒
- 全基因組擴增試劑盒
- 亞硫酸氫鹽轉化試劑盒
- RNA定序試劑盒
- 其他
儀器
酵素
服務

技術洞察：

DNA甲基化
組蛋白甲基化
組蛋白乙醯化
大型非編碼RNA
MicroRNA修飾
染色質結構

應用程式洞察：

腫瘤學
- 實體腫瘤
- 液體腫瘤
非腫瘤學
- 發炎性疾病
- 代謝性疾病
- 傳染病
- 心血管疾病
- 其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本表觀遺傳學市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本表觀遺傳學市場有何影響？
日本表觀遺傳學市場依產品分類是怎樣的？
日本表觀遺傳學市場按技術分類的分佈如何？
日本表觀遺傳學市場根據應用程式如何分類？
日本表觀遺傳學市場的價值鏈分為哪些階段？
日本表觀遺傳學的主要促進因素和挑戰是什麼？
日本表觀遺傳學市場的結構是怎麼樣的？主要參與者是誰？
日本表觀遺傳學市場的競爭程度如何？

本報告回答的關鍵問題：

日本表觀遺傳學市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本表觀遺傳學市場有何影響？
日本表觀遺傳學市場依產品分類是怎樣的？
日本表觀遺傳學市場按技術分類的分佈如何？
日本表觀遺傳學市場根據應用程式如何分類？
日本表觀遺傳學市場的價值鏈分為哪些階段？
日本表觀遺傳學的主要促進因素和挑戰是什麼？
日本表觀遺傳學市場的結構是怎麼樣的？主要參與者是誰？
日本表觀遺傳學市場的競爭程度如何？

Japan epigenetics market size reached USD 160.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 457.0 Million by 2033, exhibiting a growth rate (CAGR) of 12.4% during 2025-2033. The escalating cases of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with the rising demand for epigenetic research and diagnostics to manage these conditions, are primarily driving the market.

Epigenetics refers to changes in gene expression that occur without alterations to the underlying DNA sequence. It involves modifications to the structure of DNA and its associated proteins, which can turn genes on or off, influencing an organism's traits and development. Epigenetic mechanisms include DNA methylation, where methyl groups are added to DNA, and histone modifications, which alter the packaging of DNA in the cell nucleus. These modifications can be influenced by environmental factors, lifestyle choices, and even experiences across generations. Epigenetics plays a crucial role in various biological processes, such as embryonic development, cellular differentiation, and the regulation of gene activity. It also has implications for health and disease, as epigenetic changes can contribute to the development of diseases like cancer, cardiovascular disease, and mental health disorders. Understanding epigenetics has the potential to shed light on the interplay between genetics and the environment, providing insights into gene regulations and their impact on health and well-being.

Japan Epigenetics Market Trends:

The epigenetics market in Japan has witnessed remarkable growth in recent years, primarily owing to its potential to revolutionize understanding of gene regulation and its implications in various fields. Firstly, advancements in technology, such as next-generation sequencing and high-throughput assays, have propelled the epigenetics market forward. These tools enable researchers to analyze DNA methylation, histone modifications, and non-coding RNA expression at an unprecedented scale and accuracy. Furthermore, the rising prevalence of complex diseases, including cancer, neurological disorders, and metabolic conditions, has driven the demand for epigenetic studies. Epigenetic alterations have been linked to the development and progression of these diseases, creating a pressing need for targeted therapies and diagnostic tools. Additionally, the growing awareness of the role of epigenetics in personalized medicine has sparked interest among pharmaceutical companies, further stimulating the market. Moreover, government and private investments in epigenetics research have surged, fostering innovation and collaboration among academic institutions and biotechnology firms. This financial support has accelerated the development of epigenetic drugs and diagnostic solutions. Lastly, the increasing adoption of epigenetic testing in clinical settings, coupled with a growing aging population, is expected to drive the epigenetics market in Japan during the forecast period.

Japan Epigenetics Market Segmentation:

Product Insights:

Reagents
Kits
- Chip Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
Instruments
Enzymes
Services

Technology Insights:

DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-Coding RNA
MicroRNA Modification
Chromatin Structures

Application Insights:

Oncology
- Solid Tumors
- Liquid Tumors
Non-Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan epigenetics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan epigenetics market?
What is the breakup of the Japan epigenetics market on the basis of product?
What is the breakup of the Japan epigenetics market on the basis of technology?
What is the breakup of the Japan epigenetics market on the basis of application?
What are the various stages in the value chain of the Japan epigenetics market?
What are the key driving factors and challenges in the Japan epigenetics?
What is the structure of the Japan epigenetics market and who are the key players?
What is the degree of competition in the Japan epigenetics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Epigenetics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Epigenetics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Epigenetics Market - Breakup by Product

6.1 Reagents
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Kits
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Chip Sequencing Kit
  - 6.2.3.2 Whole Genomic Amplification Kit
  - 6.2.3.3 Bisulfite Conversion Kit
  - 6.2.3.4 RNA Sequencing Kit
  - 6.2.3.5 Others
- 6.2.4 Market Forecast (2025-2033)
6.3 Instruments
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Enzymes
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Services
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)

7 Japan Epigenetics Market - Breakup by Technology

7.1 DNA Methylation
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Histone Methylation
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Histone Acetylation
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Large Non-Coding RNA
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 MicroRNA Modification
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Chromatin Structures
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2019-2024)
- 7.6.3 Market Forecast (2025-2033)

8 Japan Epigenetics Market - Breakup by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Segmentation
  - 8.1.3.1 Solid Tumors
  - 8.1.3.2 Liquid Tumors
- 8.1.4 Market Forecast (2025-2033)
8.2 non-oncology
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Segmentation
  - 8.2.3.1 Inflammatory Diseases
  - 8.2.3.2 Metabolic Diseases
  - 8.2.3.3 Infectious Diseases
  - 8.2.3.4 cardiovascular diseases
  - 8.2.3.5 Others
- 8.2.4 Market Forecast (2025-2033)

9 Japan Epigenetics Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Epigenetics Market - Industry Analysis

11.1 Drivers, Restraints and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis